1. Home
  2. NRXP vs HLP Comparison

NRXP vs HLP Comparison

Compare NRXP & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • HLP
  • Stock Information
  • Founded
  • NRXP 2015
  • HLP 2021
  • Country
  • NRXP United States
  • HLP China
  • Employees
  • NRXP N/A
  • HLP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • HLP Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • HLP Industrials
  • Exchange
  • NRXP Nasdaq
  • HLP Nasdaq
  • Market Cap
  • NRXP 58.5M
  • HLP 52.1M
  • IPO Year
  • NRXP N/A
  • HLP 2023
  • Fundamental
  • Price
  • NRXP $2.84
  • HLP $0.66
  • Analyst Decision
  • NRXP Strong Buy
  • HLP
  • Analyst Count
  • NRXP 5
  • HLP 0
  • Target Price
  • NRXP $31.40
  • HLP N/A
  • AVG Volume (30 Days)
  • NRXP 562.9K
  • HLP 169.4K
  • Earning Date
  • NRXP 08-18-2025
  • HLP 09-19-2025
  • Dividend Yield
  • NRXP N/A
  • HLP N/A
  • EPS Growth
  • NRXP N/A
  • HLP N/A
  • EPS
  • NRXP N/A
  • HLP N/A
  • Revenue
  • NRXP N/A
  • HLP $14,105,620.00
  • Revenue This Year
  • NRXP N/A
  • HLP N/A
  • Revenue Next Year
  • NRXP $231.16
  • HLP N/A
  • P/E Ratio
  • NRXP N/A
  • HLP N/A
  • Revenue Growth
  • NRXP N/A
  • HLP N/A
  • 52 Week Low
  • NRXP $1.10
  • HLP $0.61
  • 52 Week High
  • NRXP $6.01
  • HLP $2.00
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 56.21
  • HLP 46.25
  • Support Level
  • NRXP $2.26
  • HLP $0.66
  • Resistance Level
  • NRXP $2.81
  • HLP $0.76
  • Average True Range (ATR)
  • NRXP 0.23
  • HLP 0.06
  • MACD
  • NRXP 0.04
  • HLP 0.00
  • Stochastic Oscillator
  • NRXP 78.38
  • HLP 27.66

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About HLP Hongli Group Inc.

Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.

Share on Social Networks: